4-methoxyamphetamine has been researched along with paroxetine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Callaghan, PD; Daws, LC; Farrand, K; Hughes, P; Irvine, RJ; Salem, A | 1 |
Abe, T; Kato, S; Onishi, Y; Yamamoto, K | 1 |
2 other study(ies) available for 4-methoxyamphetamine and paroxetine
Article | Year |
---|---|
Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamines; Animals; Binding, Competitive; Brain Chemistry; Cerebral Cortex; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Electrochemistry; Hallucinogens; Hydroxyindoleacetic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptic Transmission; Time Factors | 2006 |
[Case report of an elderly woman who developed a pain disorder following her husband's death].
Topics: Aged; Antidepressive Agents, Second-Generation; Death; Depression; Female; Genitalia, Female; Humans; Life Change Events; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Spouses; Treatment Outcome | 2006 |